JPS5640666A - Aroylethenylpiperidinobutyrophenone antipsychotic drug - Google Patents

Aroylethenylpiperidinobutyrophenone antipsychotic drug

Info

Publication number
JPS5640666A
JPS5640666A JP11652680A JP11652680A JPS5640666A JP S5640666 A JPS5640666 A JP S5640666A JP 11652680 A JP11652680 A JP 11652680A JP 11652680 A JP11652680 A JP 11652680A JP S5640666 A JPS5640666 A JP S5640666A
Authority
JP
Japan
Prior art keywords
aroylethenylpiperidinobutyrophenone
antipsychotic drug
antipsychotic
drug
aroylethenylpiperidinobutyrophenone antipsychotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11652680A
Other languages
English (en)
Other versions
JPS6341389B2 (ja
Inventor
Ei Kaaru Arubaato
Ei Fuaaru Robaato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of JPS5640666A publication Critical patent/JPS5640666A/ja
Publication of JPS6341389B2 publication Critical patent/JPS6341389B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP11652680A 1979-09-04 1980-08-26 Aroylethenylpiperidinobutyrophenone antipsychotic drug Granted JPS5640666A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/072,499 US4283404A (en) 1979-09-04 1979-09-04 Aroylethenylpiperidinobutyrophenone antipsychotic agents

Publications (2)

Publication Number Publication Date
JPS5640666A true JPS5640666A (en) 1981-04-16
JPS6341389B2 JPS6341389B2 (ja) 1988-08-17

Family

ID=22107983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11652680A Granted JPS5640666A (en) 1979-09-04 1980-08-26 Aroylethenylpiperidinobutyrophenone antipsychotic drug

Country Status (14)

Country Link
US (1) US4283404A (ja)
JP (1) JPS5640666A (ja)
AU (1) AU538603B2 (ja)
BE (1) BE885018A (ja)
CA (1) CA1147735A (ja)
CH (1) CH646951A5 (ja)
DE (1) DE3031929A1 (ja)
ES (1) ES8106144A1 (ja)
FR (1) FR2464252A1 (ja)
GB (3) GB2057444B (ja)
IL (1) IL60743A (ja)
IT (1) IT1145386B (ja)
NL (1) NL8004836A (ja)
ZA (1) ZA804664B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
EP2027087A2 (en) 2006-05-18 2009-02-25 MannKind Corporation Intracellular kinase inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
GB979555A (en) * 1962-01-17 1965-01-06 Bellon Labor Sa Roger New benzyl piperidyl ketones
US3689492A (en) * 1965-09-10 1972-09-05 Hans Detlef Schroeder 1-{8 4{40 -OXO-4-(p-FLUOROPHENYL)-n-BUTYL-1{40 {9 -4-ACETYL-4-(m-HYDROXY-PHENYL-PIPERIDINE
US3646014A (en) * 1966-05-09 1972-02-29 Aldrich Chem Co Inc Chemical compounds
US3484446A (en) * 1967-01-16 1969-12-16 Aldrich Chem Co Inc 1-(3-(4-fluorobenzoyl)propyl) - and 1 - (1,1-ethylenedioxy - 1 - (4 - fluorophenyl)-4-butyl)-4-piperidyl carbamates
NL130760C (ja) * 1967-01-25
CH533114A (de) * 1967-12-01 1973-03-15 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Zimtsäureamiden
CH516557A (de) * 1967-12-01 1971-12-15 Thomae Gmbh Dr K Verfahren zur Herstellung neuer Zimtsäureamide
US3576810A (en) * 1968-06-20 1971-04-27 Robins Co Inc A H 1-substituted-3-(-4)-aroylpiperidines
US3637712A (en) * 1970-01-26 1972-01-25 Bristol Myers Co Piperidylpropanol compounds
US3852455A (en) * 1970-11-27 1974-12-03 Richardson Merrell Inc 4-{8 4({60 hydroxybenzyl)piperidino{9 -4-fluorobutyrophenone derivatives as tranquilizers
ZA717147B (en) * 1970-11-27 1972-07-26 Richardson Merrell Inc 4-(4-(alpha-hydroxybenzyl)piperidino)-4'-fluorobutyrophenone derivatives
US3816443A (en) * 1972-02-17 1974-06-11 Merck & Co Inc 4-(benzothiazol-2-yl)fluoro phenyl-acetic acids
US3797932A (en) * 1972-10-31 1974-03-19 Eastman Kodak Co Vibration isolation arrangement for aperture card photographic copying machine
US4101662A (en) * 1973-05-03 1978-07-18 A. H. Robins Company, Incorporated Method for inhibiting emesis and compositions therefor
SE7409245L (ja) * 1973-07-19 1975-01-20 Robins Co Inc A H
GB1535791A (en) * 1975-05-07 1978-12-13 Ferrosan Ab Derivatives of 4-piperidinol
CH602642A5 (ja) * 1975-11-14 1978-07-31 Orgamol Sa

Also Published As

Publication number Publication date
GB2121032A (en) 1983-12-14
US4283404A (en) 1981-08-11
GB2057444B (en) 1983-11-30
JPS6341389B2 (ja) 1988-08-17
IL60743A0 (en) 1980-10-26
GB2057444A (en) 1981-04-01
GB2121032B (en) 1984-06-06
AU6148980A (en) 1981-03-12
CH646951A5 (de) 1984-12-28
GB2121033B (en) 1984-05-16
IT8049598A0 (it) 1980-09-02
ZA804664B (en) 1981-07-29
BE885018A (fr) 1980-12-31
FR2464252B1 (ja) 1983-05-27
GB8302742D0 (en) 1983-03-02
ES494223A0 (es) 1981-08-01
AU538603B2 (en) 1984-08-23
IL60743A (en) 1984-07-31
FR2464252A1 (fr) 1981-03-06
NL8004836A (nl) 1981-03-06
DE3031929A1 (de) 1981-03-26
CA1147735A (en) 1983-06-07
GB2121033A (en) 1983-12-14
ES8106144A1 (es) 1981-08-01
GB8303500D0 (en) 1983-03-16
IT1145386B (it) 1986-11-05

Similar Documents

Publication Publication Date Title
DE3068632D1 (en) Syringes
GB2058228B (en) Syringe
GB2065410B (en) Proximity sensing
DE3062822D1 (en) Syringe
ZA806210B (en) Syringe
GB2055813B (en) Aminoalkylbenzene derivatives
GB8320051D0 (en) Heterocyclic oxyphenols
GB2054560B (en) Benzylimdiazole derivatives
GB2058765B (en) Deformyltylosin derivatives
GB2050172B (en) Syringes
GB2051821B (en) Enkephalin derivatives
JPS55115883A (en) Antihistaminic
GB2046734B (en) 7-(-oximino-pyrazolyl(-acetamido)-cephen derivatives
GB2055818B (en) 3-methyleneazetidine derivatives
GB2056452B (en) Halovincamone derivatives
ZA803338B (en) Novel enkephalin derivatives
ZA802009B (en) Pharmaceutical compounds
CU35300A (en) Pyrrholidine derivatives
GB2052493B (en) Imidazobenzodiazepine derivatives
GB2065111B (en) Decaprenylamine derivatives
GB2053899B (en) Terahydrophthalamide derivatives
GB2062464B (en) Eburnamenine derivatives
GB2055368B (en) E-homoeburnane derivatives
JPS5640666A (en) Aroylethenylpiperidinobutyrophenone antipsychotic drug
GB2050377B (en) Pyrazinoquinoxaline derivatives